products (8-10).
biochemical and biological steps related to the process of replication study. Plasmid DNA containing the COIII gene was extracted as described previously (17). One mg of plasmid DNA containing the COIII or tumor formation. Carcinogenic hormones are widely believed 2Ј-deoxyguanosine-3Ј-monophosphate (dGMP) (dissolved in 1.6 ml water) to belong to the latter group of chemicals because of their was reacted with 1 mg of 3,4-EQ (dissolved in 1.0 ml DMSO) for 4 h at proliferative effect on target cells. Estrogens have been shown 37°C. Reaction mixtures were extracted four times with chloroform and six to induce mammary, pituitary, cervical, and uterine tumors in times with water-saturated ethyl acetate. The aqueous phase was precipitated rats, mice and guinea-pigs (2). The carcinogenicity of estrogens with ice-cold 100% ethanol. The DNA pellet was reconstituted in 10 mM citrate buffer, pH 6.0 and the concentration of DNA or dGMP was estimated has been attributed to either alkylation of cellular molecules at 260 nm. The samples were stored at -70°C unless used immediately for and/or redox-cycling, generation of active radicals and DNA adduct analysis.
damage. Metabolic activation of estrogens leading to the DNA adduct analysis by 32 P-post-labeling formation of catechol estrogens is believed to be a prerequisite
The analysis of covalent modification in DNA was carried out by the 32 Pfor its genotoxic effects (3,4). Previous studies in our laborapost-labeling technique of Reddy and Randerath (15). DNA (10 µg) was tories have shown that 3,4-estrone quinone (3,4-EQ*) can digested with micrococcal nuclease, spleen phosphodiesterase, and nuclease P1 as described previously (15). The resolution of 32 P-post-labeled adduct spots was carried out with unmodified nucleotides on polyethyleneimine-*Abbreviations: 3,4-EQ, 3,4-estrone quinone; 4-OHE 1 , 4-hydroxyestrone; dGMP, 2Ј-deoxyguanosine-3Ј-monophosphate; dNTP, deoxynucleotide tricellulose TLC plates using the following solvents: D1, 2.3 M sodium phosphate, pH 5.7; D3, 4.2 M lithium formate and 6.8 urea, pH 3.3; D4, phosphate. 0.8 M sodium phosphate, 0.5 M Tris and 8.5 M urea, pH 8.2; and D5, 1.7 M sodium phosphate, pH 6.0. The 32 P-labeled adduct spots were detected by audioradiography using Kodak X-Omat films. For rechromatography the spots containing 32 P-post-labeled adducts were excised from TLC plates, and levels of radioactivity were determined by Cerenkov counting. Aliquots containing 1000 dpm were applied to PEI cellulose plates and chromatograms were gene by 3,4-EQ. Lanes 1-3 represent the COIII gene that was polymerized Base specific modifications assayed by DNA polymerase arrest assay without any dideoxynucleotides. Lane 1 contained the unreacted COIII The non-reacted and reacted COIII gene were used as DNA templates to gene. Lane 2 contained the COIII gene reacted with 1.0 mg/ml 3,4-EQ. study the influence of 3,4-EQ adduction on in vitro synthesis using DNA Lane 3 contained the COIII gene reacted with 0.25 mg/ml of 3,4-EQ. Lanes polymerase arrest assay in which prematurely terminated replication products denoted C, T, A, G represent sequencing reactions of the unreacted COIII were separated on a DNA sequencing gel (18). The reacted and non-reacted gene with the corresponding nucleotides (cytosine, thymine, adenine, and COIII genes were polymerized with the Sequenase enzyme (T7 DNA guanine, respectively). The actual gene sequence is complementary to the polymerase) without any dideoxynucleotide polymerase inhibitor. The unresequence shown above. acted COIII gene was also sequenced as recommended by the manufacturer's protocol using dideoxynucleotide as an inhibitor of polymerase elongation reaction. The stop sites in the reacted COIII gene was compared to the stop generated several adducts (Figure 1, panel B) . The chromatosites in the complete sequence to determine where 3,4-EQ binds to DNA. graphic mobilities of adducts 1, 3 and 4 were found to be similar to that of the adducts that were obtained from incubation Results and discussion of 3,4-EQ with dGMP ( Figure 1, panel C) . The COIII gene not incubated with 3,4-EQ did not reveal any adducts (Figure 1 , DNA adduct formation plays a key role in the initiation of carcinogenenesis by genotoxic chemicals. While estrogens panel A). To further characterize the nature of the 3,4-EQ-DNA adducts, the major adduct obtained from reaction of 3,4-have been shown to induce tumors in animal models, the exact nature of the carcinogenic process initiated by estrogens has EQ with COIII gene (Figure 1 , panel B, adduct 1) was isolated from the 2-D maps and rechromatographed on polyethyleneimyet to be elucidated. Although previous investigations have shown that catechol/quinone estrogens form DNA adducts, as ine-cellulose thin layer sheets using the two solvents, 4.2 M lithium formate and 6.8 M urea, pH 3.3, and 2-propanol/0.4 M analysed by 32 P-post-labeling techniques (11,12), these studies did not provide any information about the site(s) of interaction ammonium formate, pH 6.2 (1:1, v:v). The chromatographic mobility of adduct 1 was found to be identical to that obtained of estrogens with DNA. To ascertain the nature of the interaction of estrogens with DNA, 3,4-EQ was incubated with the from reaction of dGMP with 3,4-EQ (Figure 2 ), indicating that one of the COIII-3,4-EQ adducts is quinone-dGMP. COIII gene for 4 h, the gene was extracted and analysed by 32 P-post-labeling. The analysis revealed that estrogen quinone
To determine the sites of reaction of estrogens with DNA, with Gua in COIII gene, is also capable of forming adducts (1996) polymerase is a robust enzyme because it lacks 3Ј-5Ј exonucle- malian polymerase in vivo. Thus, 3,4-EQ-induced DNA polymerase may play a significant role in genotoxicity. The results obtained from this investigation may be of significant importance not only in delineating the pathway involved in adduct formation with DNA, but also may be of importance in providing an insight into the mechanism(s) of estrogen carcinogenesis. Studies are underway to determine the structure(s) of the estrogen-nucleic acid adducts derived from reaction of 3,4-EQ with COIII gene.
